This article disusses management of hypertrophic cardiomyopathy and how contemporary treatments have effectively transformed HCM into a highly treatable condition with relatively low morbidity/mortality.

Editors

Editor-in-Chief
Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Authors
Barry J. Maron, MD

Important Dates

Date of Release: January 24, 2022
Term of Approval/Date of CME/MOC Expiration: January 23, 2023